BIOVIE INC. (BIVIW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in USD.

Revenue Quarterly

0 Q3 '15: 0 Q3 '16: 0 Q3 '15 Q3 '16

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '15: -54.6K Q4 '15: -49.9K Q1 '16: -57.9K Q2 '16: -269.6K Q3 '16: -351.4K Q4 '16: -357.8K Q1 '17: -400.5K Q2 '17: -443.9K Q3 '17: -662.2K Q4 '17: -494.8K Q1 '18: -691.2K Q2 '18: -523.9K Q3 '18: -491.4K Q4 '18: -500.9K Q1 '19: -848.3K Q2 '19: -656K Q3 '19: -706.2K Q4 '19: -710.4K Q1 '20: -699.3K Q2 '20: -577K Q3 '20: -386.8K Q4 '20: -3.1M Q1 '21: -3M Q2 '21: -131.6M Q3 '21: -5.5M Q4 '21: -6.7M Q1 '22: -5.7M Q2 '22: -9.3M Q3 '22: -8.8M Q4 '22: -11.5M Q1 '23: -13.8M Q2 '23: -11M Q3 '23: -10.9M Q4 '23: -8.8M Q1 '24: -7.7M Q2 '24: -4.8M Q3 '24: -4.1M Q4 '24: -7.3M Q1 '25: -3M Q2 '25: -3.7M Q3 '25: -5.3M Q4 '25: -6.3M Q1 '26: -5.4M Q2 '26: -5.7M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Net Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q2 '13: -17.5K Q3 '13: -53.5K Q4 '13: -47.1K Q1 '14: -48K Q2 '14: -173.2K Q3 '14: -58.8K Q4 '14: -70.5K Q1 '15: -49K Q2 '15: -54.8K Q3 '15: -54.6K Q4 '15: -49.9K Q1 '16: -57.8K Q2 '16: -269.7K Q3 '16: -351.3K Q4 '16: -357.8K Q1 '17: -178.5K Q2 '17: -443K Q3 '17: -662.8K Q4 '17: -502.7K Q1 '18: -692.6K Q2 '18: -576K Q3 '18: -439.9K Q4 '18: -500.5K Q1 '19: -848K Q2 '19: -655.9K Q3 '19: -3.8M Q4 '19: 6.7M Q1 '20: -366.4K Q2 '20: -19.2M Q3 '20: 7.3M Q4 '20: -3.1M Q1 '21: -3M Q2 '21: -131.5M Q3 '21: -5.5M Q4 '21: -5.4M Q1 '22: -7M Q2 '22: -8.1M Q3 '22: -10.4M Q4 '22: -15.7M Q1 '23: -15M Q2 '23: -9.1M Q3 '23: -10.7M Q4 '23: -8.4M Q1 '24: -8.1M Q2 '24: -4.9M Q3 '24: -4.2M Q4 '24: -7.1M Q1 '25: -2.8M Q2 '25: -3.5M Q3 '25: -5.1M Q4 '25: -6.1M Q1 '26: -5.3M Q2 '26: -5.6M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q2 '13: -2.5K Q3 '13: -59.8K Q4 '13: -39K Q1 '14: -61.6K Q2 '14: -12.4K Q3 '14: -14.7K Q4 '14: -30.1K Q1 '15: -9.5K Q2 '15: -11.1K Q3 '15: -2K Q4 '15: -16K Q1 '16: -16.3K Q2 '16: -119.4K Q3 '16: -128K Q4 '16: -101.7K Q1 '17: -268.7K Q2 '17: -125.2K Q3 '17: -203.4K Q4 '17: -159.9K Q1 '18: -48.7K Q2 '18: -209.3K Q3 '18: -441.9K Q4 '18: -769.1K Q1 '19: -658.9K Q2 '19: -631.7K Q3 '19: -590.9K Q4 '19: -275.9K Q1 '20: -401.4K Q2 '20: -360K Q3 '20: -1.1M Q4 '20: -1.3M Q1 '21: -1M Q2 '21: -7M Q3 '21: -2.5M Q4 '21: -4.7M Q1 '22: -5.9M Q2 '22: -5.9M Q3 '22: -9.2M Q4 '22: -8M Q1 '23: -11.7M Q2 '23: -11.3M Q3 '23: -12.2M Q4 '23: -5.9M Q1 '24: -5.9M Q2 '24: -4M Q3 '24: -3.6M Q4 '24: -8.6M Q1 '25: -1.3M Q2 '25: -5.6M Q3 '25: -3M Q4 '25: -4.4M Q1 '26: -7.4M Q2 '26: -4.1M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 15M 30M 45M Q4 '18: 2.5M Q1 '19: 2.5M Q3 '19: 4.1M Q4 '19: 5.2M Q1 '20: 5.2M Q3 '20: 6M Q4 '20: 13.9M Q1 '21: 13.9M Q3 '21: 23.7M Q4 '21: 25M Q1 '22: 25M Q3 '22: 27.2M Q4 '22: 31.2M Q1 '23: 35.3M Q3 '23: 3.7M Q4 '23: 3.8M Q1 '24: 4.5M Q3 '24: 639.8K Q4 '24: 1.6M Q1 '25: 1.9M Q3 '25: 5.2M Q4 '25: 7.9M Q1 '26: 7.5M Q1 '19 Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q1 '14: 0.00 Q2 '14: 0.00 Q3 '14: 0.00 Q4 '14: 0.00 Q1 '15: 0.00 Q2 '15: 0.00 Q3 '15: 0.00 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: 0.00 Q1 '17: 0.00 Q2 '17: 0.00 Q3 '17: -0.01 Q4 '17: -0.02 Q1 '18: -0.03 Q2 '18: -0.04 Q3 '18: -0.03 Q4 '18: -0.22 Q1 '19: -0.55 Q2 '19: -0.79 Q3 '21: -10.85 Q4 '21: -10.85 Q1 '22: -10.91 Q2 '22: -1.06 Q3 '22: -1.21 Q4 '22: -1.49 Q1 '23: -1.64 Q2 '23: -15.46 Q3 '23: -18.00 Q4 '23: -19.70 Q1 '24: -21.27 Q2 '24: -73.13 Q3 '24: -77.21 Q4 '24: -79.56 Q1 '25: -79.07 Q2 '25: -14.50 Q3 '25: -8.48 Q4 '25: -4.70 Q1 '26: -3.89 Q2 '26: -3.15 Q2 '15 Q4 '16 Q2 '18 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.